Dynamix Pharmaceuticals

Developing small molecule kinase II inhibitors for cancer and autoimmune diseases

placeRehovot, Central District, Israel calendar_todayFounded 2009 groups11 employees language dynxp.com

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 242 times.

YearFilings
20123
20132
20142

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon